Axelopran/Oxycodone

阿西洛仑/羟考酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAxelopran/Oxycodone
Drug Alias Name阿西洛仑+羟考酮Oxycodone/TD-1211TD-1211/oxycodone羟考酮/阿赛普兰羟考酮/阿西洛仑 +[15
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor antagonistsOpioid receptors agonists
TargetsOpioid receptorsMu opioid receptor
Therapy Area/IndicationsConstipationPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes OxycodoneAxelopran
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheravance Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTheravance Biopharma Inc
Inactive CompaniesN/A
Active IndicationsConstipationPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A